首页> 外国专利> BCMA-targeted chimeric antigen receptor, CD19-targeted chimeric antigen receptor, and combination therapy

BCMA-targeted chimeric antigen receptor, CD19-targeted chimeric antigen receptor, and combination therapy

机译：BCMA靶向嵌合抗原受体，CD19靶向嵌合抗原受体和联合治疗

页面导航

摘要
著录项
相似文献

摘要

The present invention provides compositions and methods for treating diseases associated with the expression of BCMA. The invention also relates to methods of administering BCMA-targeted chimeric antigen receptor (CAR) therapies and additional therapeutic agents.

机译：本发明提供了用于治疗与BCMA表达有关的疾病的组合物和方法。本发明还涉及施用靶向BCMA的嵌合抗原受体（CAR）疗法和其他治疗剂的方法。

著录项

公开/公告号KR20200089285A

专利类型
公开/公告日2020-07-24

原文格式PDF
申请/专利权人 노파르티스 아게;더 트러스티스 오브 더 유니버시티 오브 펜실바니아;
展开▼

申请/专利号KR20207016673
发明设计人 가폴 알프레드;코헨 아담 데이비드;밀론 마이클 씨.;플레사 가브리엘라;스타트마우어 에드워드 에이.;준 카를 에이치.;
展开▼

申请日2018-11-15
分类号A61K35/17;A61K31/454;A61K31/675;A61K31/7076;A61K39;A61K45/06;A61P35/02;C07K14/705;C07K14/715;
国家 KR
入库时间 2022-08-21 11:06:22

相似文献

专利
外文文献
中文文献